comparemela.com

Latest Breaking News On - Byerich martin - Page 14 : comparemela.com

IgG4-related disease management still reliant on prednisone as new therapies emerge

DESTIN, Fla. — IgG4-related disease may be regarded as this century’s “greatest mimicker,” but upcoming therapies and discoveries are reasons for excitement, according to a speaker at the 2023 Congress of Clinical Rheumatology-East.

Insufficient hydroxychloroquine, excessive prednisone may hinder LLDAS, remission in lupus

DESTIN, Fla. — Low disease activity and remission are achievable for patients with lupus if clinicians “minimize the prednisone” and administer adequate hydroxychloroquine, noted a speaker at the 2023 Congress of Clinical Rheumatology-East.

Despite retinopathy concerns, hydroxychloroquine still proven to boost survival in lupus

DESTIN, Fla. — Hydroxychloroquine remains one of the most important drugs in lupus management and should be used as background therapy in nearly all cases, according to a speaker at the Congress of Clinical Rheumatology East annual meeting. “It is the most important medicine,” Michelle Petri, MDMPH, the director of the Lupus Center at Johns Hopkins University School of Medicine,

Hunting for the elusive Sjögren s diagnosis: How multiple specialties can improve delays

In rheumatology, there is no shortage of conditions that are difficult to diagnose, with diseases like fibromyalgia and systemic lupus erythematosus sometimes taking years before being officially identified — leading to adverse outcomes.However, one condition that might be even more difficult to nail down is Sjögren’s syndrome, according to Pulukool Sandhya, MD, a rheumatologist at

Cyclobenzaprine reduces pain, improves sleep quality in patients with fibromyalgia

Patients with fibromyalgia who receive a sublingual tablet form cyclobenzaprine experience reduced daily pain, and improved sleep quality, compared with those who received placebo, according to a press release from the drug’s manufacturer.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.